Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.85+0.02 (+1.98%)
Close on Nov 18, 2026Market cap $14.23MP/E –Yield –
Marker Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Marker Therapeutics's pe ratio was 1.0× on Oct 31, 2016.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Oct 31, 2016 | 1.0× | – |
See a number that looks wrong?